Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22160377)

  • 1. EGFL7: a unique angiogenic signaling factor in vascular development and disease.
    Nichol D; Stuhlmann H
    Blood; 2012 Feb; 119(6):1345-52. PubMed ID: 22160377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7.
    Nichol D; Shawber C; Fitch MJ; Bambino K; Sharma A; Kitajewski J; Stuhlmann H
    Blood; 2010 Dec; 116(26):6133-43. PubMed ID: 20947685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFL7 ligates αvβ3 integrin to enhance vessel formation.
    Nikolic I; Stankovic ND; Bicker F; Meister J; Braun H; Awwad K; Baumgart J; Simon K; Thal SC; Patra C; Harter PN; Plate KH; Engel FB; Dimmeler S; Eble JA; Mittelbronn M; Schäfer MK; Jungblut B; Chavakis E; Fleming I; Schmidt MHH
    Blood; 2013 Apr; 121(15):3041-50. PubMed ID: 23386126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of EGFL7 in human cancers: A review.
    de Oliveira C; Gonçalves PG; Bidinotto LT
    J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egfl7 is differentially expressed in arteries and veins during retinal vascular development.
    Poissonnier L; Villain G; Soncin F; Mattot V
    PLoS One; 2014; 9(3):e90455. PubMed ID: 24595089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis.
    Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M
    Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal.
    Schmidt MHH; Bicker F; Nikolic I; Meister J; Babuke T; Picuric S; Müller-Esterl W; Plate KH; Dikic I
    Nat Cell Biol; 2009 Jul; 11(7):873-80. PubMed ID: 19503073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway.
    Charpentier MS; Christine KS; Amin NM; Dorr KM; Kushner EJ; Bautch VL; Taylor JM; Conlon FL
    Dev Cell; 2013 Apr; 25(2):132-43. PubMed ID: 23639441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury.
    Campagnolo L; Leahy A; Chitnis S; Koschnick S; Fitch MJ; Fallon JT; Loskutoff D; Taubman MB; Stuhlmann H
    Am J Pathol; 2005 Jul; 167(1):275-84. PubMed ID: 15972971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model.
    Usuba R; Pauty J; Soncin F; Matsunaga YT
    Biomaterials; 2019 Mar; 197():305-316. PubMed ID: 30684886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.
    Pinte S; Delfortrie S; Havet C; Villain G; Mattot V; Soncin F
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor-like domain 7 is a novel inhibitor of neutrophil adhesion to coronary artery endothelial cells injured by calcineurin inhibition.
    Badiwala MV; Guha D; Tumiati L; Joseph J; Ghashghai A; Ross HJ; Delgado DH; Rao V
    Circulation; 2011 Sep; 124(11 Suppl):S197-203. PubMed ID: 21911813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAGP-1 and fibronectin control EGFL7 functions by driving its deposition into distinct endothelial extracellular matrix locations.
    Villain G; Lelievre E; Broekelmann T; Gayet O; Havet C; Werkmeister E; Mecham R; Dusetti N; Soncin F; Mattot V
    FEBS J; 2018 Dec; 285(23):4394-4412. PubMed ID: 30338930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis.
    Veikkola T; Alitalo K
    Dev Cell; 2002 Sep; 3(3):302-4. PubMed ID: 12361591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFL7 Mediates BMP9-Induced Sprouting Angiogenesis of Endothelial Cells Derived from Human Embryonic Stem Cells.
    Richter A; Alexdottir MS; Magnus SH; Richter TR; Morikawa M; Zwijsen A; Valdimarsdottir G
    Stem Cell Reports; 2019 Jun; 12(6):1250-1259. PubMed ID: 31155507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
    Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
    J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia.
    Bill M; Pathmanathan A; Karunasiri M; Shen C; Burke MH; Ranganathan P; Papaioannou D; Zitzer NC; Snyder K; LaRocco A; Walker AE; Brannan ZJ; Nalin AP; Freud AG; Dikov MM; Zhang X; Bloomfield CD; Garzon R; Dorrance AM
    Clin Cancer Res; 2020 Feb; 26(3):669-678. PubMed ID: 31672772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
    Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
    Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFL7 enhances surface expression of integrin α
    Dudvarski Stanković N; Bicker F; Keller S; Jones DT; Harter PN; Kienzle A; Gillmann C; Arnold P; Golebiewska A; Keunen O; Giese A; von Deimling A; Bäuerle T; Niclou SP; Mittelbronn M; Ye W; Pfister SM; Schmidt MHH
    EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30065025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.